Latest News and Press Releases

Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants L'approbation dans l'urticaire chronique spontanée...

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is...

London, United Kingdom, April 13, 2026 (GLOBE NEWSWIRE) -- The United Kingdom has a vibrant and diverse startup and small tech ecosystem that drives significant economic output and supports more...

Did you buy DRVN common stock between May 3, 2023, and February 24, 2026? Affected Driven Brands Holdings Inc. Investor Summary Who: Driven Brands Holdings Inc. (NASDAQ: DRVN)What: Securities fraud...

CAPHRA supports Bangladesh’s review of its sweeping 2025 ban on vaping and other emerging nicotine products as a chance to save lives.

Did you buy IBRX securities between January 19, 2026, and March 24, 2026? Affected IBRX Investor Summary Who: ImmunityBio, Inc. (NASDAQ: IBRX)What: Securities fraud class action lawsuit filedClass...

New York City, NY, April 12, 2026 (GLOBE NEWSWIRE) -- The online casino industry is undergoing a major shift as demand for “no KYC” platforms continues to rise across the United States. Players are...

Affected PINS Investor Summary Who: Pinterest, Inc. (NYSE: PINS)What: Securities fraud class action lawsuit filedClass Period: February 7, 2025 through February 12, 2026Deadline to Seek Lead...

Weiss Ratings Plus report describes AI's Second Wind as a 2026 data shift beyond the first cycle — citing 303% historical average and new Buy signals.

CSGORoll outlines its 2026 platform updates, including new game modes, expanded rewards, and transparency-focused features in a competitive market.